Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients

Chaoyang Jiang, Hui Gao, Ling Zhang, Hua Li, Tao Zhang, Ji Ma, Bisheng LiuResearch 2020 · DOI

TL;DR

This study identifies a "blind spot" in current radiotherapy guidelines for nasopharyngeal carcinoma (NPC): the cervical region posterior to level V (PLV). The researchers found that metastatic lymph nodes in this area are a strong independent predictor of distant metastasis and poor survival, suggesting that clinical margins for radiotherapy should be expanded by 25mm in high-risk patients.

What Problem Does This Paper Address?

Nasopharyngeal carcinoma (NPC) is a highly metastatic cancer, with approximately 80% of patients presenting with cervical lymph node involvement. Accurate "mapping" of these nodes is critical because radiotherapy is the primary treatment; if a metastatic node falls outside the radiation target area (the "delineation"), the treatment is likely to fail.

Current international guidelines (specifically the 2013 European version) define boundaries for various neck levels but do not explicitly describe the region posterior to level V (PLV)—the gap between the trapezius muscle and the scapular levator. Because this area isn't standardized, it is often overlooked during treatment planning. This paper seeks to determine how often metastasis occurs in the PLV, which other nodes it correlates with, and how it impacts a patient's long-term prognosis.

Methods

The researchers conducted a retrospective study of 605 NPC patients treated between 2011 and 2017. Key methodological steps included:

  • Imaging Review: Two experienced radiologists re-evaluated CT and MRI scans to identify metastatic nodes based on size (≥10mm), necrosis, or extracapsular invasion.
  • Mapping: To standardize the data, the researchers mapped the center points of all identified PLV nodes onto a single "standard" CT scan of a patient without metastasis. They measured the vertical distance from these nodes to the anterior surface of the trapezius muscle.
  • Statistical Modeling: They used linear regression to find correlations between PLV involvement and other neck levels. Survival outcomes (Overall Survival, Progression-Free Survival, etc.) were analyzed using the Kaplan-Meier method and Cox proportional hazards models to determine if PLV involvement was an independent risk factor.

Datasets

The study utilized a clinical dataset of 605 pathologically confirmed NPC patients from two major Chinese institutions: The General Hospital of Western Theater Command and Sichuan Cancer Hospital.

  • The cohort was predominantly male (433 vs. 172 females).
  • The majority (97.52%) had WHO type II-III pathological classifications.
  • Follow-up data spanned 8 to 81 months (median of 37 months).

Key Insights and Ideas

  • The "Hidden" Gap: While the PLV region is often ignored in standard guidelines, nearly 5% of the study population showed metastasis there. This suggests the PLV should be formally recognized as a distinct cervical lymph node segment.
  • Predictive Anatomy: PLV metastasis doesn't happen in a vacuum. It is highly correlated with metastasis in levels IVa, Va, Vb, and Vc. If a clinician sees involvement in these lower neck levels, it should serve as a "red flag" to check the PLV region.
  • A Marker for Distant Failure: The most striking insight is that PLV involvement is an independent prognostic factor for Distant Metastasis-Free Survival (DMFS). Patients with PLV nodes were far more likely to see the cancer return in distant organs like the liver, lungs, or bones, rather than just recurring locally in the neck.
  • The 25mm Rule: By mapping the nodes, the authors found that 93.87% of metastatic PLV nodes were located within 25mm of the anterior surface of the trapezius. This provides a concrete, actionable measurement for radiation oncologists.

Key Results

  • Incidence: 30 out of 605 patients (4.95%) had PLV metastasis, totaling 49 individual nodes.
  • Prognostic Impact: For N3-stage patients, those with PLV metastasis had significantly worse 5-year outcomes compared to those without:
  • Overall Survival (OS): 41.8% vs. 67.3%
    • Distant Metastasis-Free Survival (DMFS): 40.6% vs. 78.4%
  • Target Delineation: The study recommends that when metastasis is present in levels IVa or V, the posterior boundary of the radiotherapy target should be moved backward by 25mm to encompass the PLV region.

Limitations and Future Work

The authors acknowledge several limitations:

  1. Retrospective Nature: The study relies on past records, which can introduce selection bias.
  2. Lack of Histopathology: Metastasis was determined via imaging (CT/MRI) rather than surgical biopsy of the PLV nodes, which is the gold standard but often impractical in NPC patients.
  3. Anatomical Variation: The "25mm rule" was calculated based on a standard patient model; however, variations in body weight, age, and neck musculature across different patients could affect the accuracy of this margin.

Future work would ideally involve prospective clinical trials to confirm whether expanding the radiotherapy margin to include the PLV actually improves survival rates without increasing side effects from radiation.

Summary updated

Abstract

Abstract Lymph node metastasis in the cervical region posterior to level V (PLV) often occurs in patients with nasopharyngeal carcinoma (NPC), but the significance and the delineation of the radiotherapy target area have not been reported. We retrospectively studied 605 cases of NPC. A total of 49 metastatic lymph nodes from the PLV region were counted. Linear regression correlation analysis suggested that lymph node metastasis in the PLV region was associated with ipsilateral level IVa, level Va, level Vb, and level Vc lymph node metastasis (all P<0.05). The 5-year OS, PFS, LRFS, and DMFS of patients with N3 NPC with or without lymph node metastasis in the PLV region were 41.8% vs 67.3% (P=0.007), 27.8% vs 48.5% (P=0.005), 92.3% vs 80.5% (P=0.521), 40.6% vs 78.4% (P<0.001), respectively. Multivariate analysis showed that lymph node metastasis in the PLV region was an independent prognostic factor for DMFS (P<0.05). In summary, NPC patients with lymph node metastasis in the PLV region had a poor prognosis and a high risk of distant metastasis. When patients have lymph node metastasis in levels IVa and V, the posterior boundary of the radiotherapy target in ipsilateral level V should be appropriately moved backward. We recommend that the margin of the PLV region may be a new cervical lymph node segment for head and neck tumors.
BibTeX
@inproceedings{jiang2020distribution,
  author = {Chaoyang Jiang and Hui Gao and Ling Zhang and Hua Li and Tao Zhang and Ji Ma and Bisheng Liu},
  title = {{Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-23395/v3},
}
Figure